WillScot
WillScot Announces Investor Conference Schedule for December 2025
WillScot Announces Investor Conference Schedule for December 2025
SCOTTSDALE, Ariz., Nov. 24, 2025 (GLOBE NEWSWIRE) -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that it will participate in the following investor conferences:
- Bank of America Leveraged Finance Conference
Date: December 2, 2025
Location: Boca Raton, Florida
- Oppenheimer Winter Industrial Summit
Date: December 10 & 11, 2025
Location: Virtual
Where available, a live webcast link will be posted on the company’s investor website. Portfolio managers and analysts who wish to request an in-person meeting should contact their sales representative at the sponsoring firm.
About WillScot
Listed on the Nasdaq stock exchange under the ticker symbol “WSC,” WillScot is the premier provider of highly innovative and turnkey space solutions in North America. The Company’s comprehensive range of products includes modular office complexes, mobile offices, classrooms, temporary restrooms, portable storage containers, protective buildings and climate-controlled units, and clearspan structures, as well as a curated selection of furnishings, appliances, and other supplementary services, ensuring turnkey solutions for its customers. Headquartered in Scottsdale, Arizona, and operating from a network of approximately 260 branch locations and additional drop lots across the United States, Canada, and Mexico, WillScot’s business services are essential for diverse customer segments spanning all sectors of the economy.
Additional Information and Where to Find It
Additional information can be found on the company's website at www.willscot.com.
Contact Information
Investor inquiries:
Charlie Wohlhuter
Investors@willscot.com
Media inquiries:
Juliana Welling
Juliana.Welling@willscot.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Junshi Biosciences25.11.2025 02:24:57 CET | Press release
Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC
Alkane Resources Limited24.11.2025 23:41:54 CET | Press release
Alkane Resources Limited: Appointment of Non-Executive Director
Novartis Pharma AG24.11.2025 23:16:33 CET | Press release
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
Rapala VMC Oyj24.11.2025 19:30:00 CET | Press release
Rapala VMC Announces Final Tender Offer Results for its Outstanding Capital Securities Issued in 2023
Circle Cardiovascular Imaging Inc.24.11.2025 19:02:00 CET | Press release
Unlock Practice Growth: Experience cvi42 at RSNA 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom